ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Adagene Inc

Adagene Inc (ADAG)

1,96
0,00
(0,00%)
Geschlossen 29 Dezember 10:00PM
1,96
0,00
(0,00%)
Nach Börsenschluss: 1:37AM
Fortg. Diagramm

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
1,96
Gebot
1,72
Fragen
2,15
Volumen
69.436
1,85 Tagesbereich 2,08
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
1,96
Handelsbeginn
1,922
Letzte Trade
12
@
1.96
Letzter Handelszeitpunkt
Finanzvolumen
US$ 135.727
VWAP
1,9547
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
44.116.671
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-4,56
Gewinn pro Aktie (EPS)
-0,43
Erlöse
21,59M
Nettogewinn
-18,95M

Über Adagene Inc

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reacti... Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Grand Cayman, Cym
Gegründet
-
Adagene Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ADAG. The last closing price for Adagene was US$1,96. Over the last year, Adagene shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Adagene currently has 44.116.671 shares in issue. The market capitalisation of Adagene is US$86,47 million. Adagene has a price to earnings ratio (PE ratio) of -4.56.

ADAG Neueste Nachrichten

Adagene Presents Two Posters with New Insights on Increased Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) and Data Reinforcing Clinical Safety and Efficacy for ADG126 as Monotherapy and in Combination with Anti-PD-1 Therapy at Soc

- Improved safety and efficacy profiles for ADG126 versus ipilimumab driven by precision masking, novel epitope-dependent antibody-dependent cellular cytotoxicity (ADCC) and partial CTLA-4...

Adagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

SAN DIEGO and SUZHOU, China, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies...

Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC

- Confirmed partial responses (PRs) doubled to four since ASCO GI in MSS CRC patients without liver and peritoneal metastases for overall response rate (ORR) of 24% (4/17) with ADG126 10 mg/kg...

Adagene to Participate in Investor Conferences in September

SAN DIEGO and SUZHOU, China, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ADAG - Frequently Asked Questions (FAQ)

What is the current Adagene share price?
The current share price of Adagene is US$ 1,96
How many Adagene shares are in issue?
Adagene has 44.116.671 shares in issue
What is the market cap of Adagene?
The market capitalisation of Adagene is USD 86,47M
What is the 1 year trading range for Adagene share price?
Adagene has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Adagene?
The price to earnings ratio of Adagene is -4,56
What is the cash to sales ratio of Adagene?
The cash to sales ratio of Adagene is 4
What is the reporting currency for Adagene?
Adagene reports financial results in USD
What is the latest annual turnover for Adagene?
The latest annual turnover of Adagene is USD 21,59M
What is the latest annual profit for Adagene?
The latest annual profit of Adagene is USD -18,95M
What is the registered address of Adagene?
The registered address for Adagene is P. O. BOX 31119 GRAND PAVILION, HIBISCUS WAY, 802 WEST BAY ROAD, GRAND CAYMAN, KY1 - 1205
Which industry sector does Adagene operate in?
Adagene operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
INTZIntrusion Inc
US$ 2,167
(381,56%)
189,59M
AILEiLearningEngines Inc
US$ 0,5932
(267,31%)
563,26M
HUBCWHub Cyber Security Ltd
US$ 0,035
(250,00%)
2,79M
GTIGraphjet Technology
US$ 0,967551
(185,83%)
398,95M
LITMSnow Lake Resources Ltd
US$ 1,61
(82,95%)
131,98M
NEUPNeuphoria Therapeutics Inc
US$ 4,11
(-92,30%)
940,73k
VIRXViracta Therapeutics Inc
US$ 0,16
(-32,49%)
9,47M
PRFXPainReform Ltd
US$ 3,48
(-28,98%)
949,52k
AIREreAlpha Tech Corporation
US$ 2,56
(-28,49%)
8,42M
AVGRAvinger Inc
US$ 0,9721
(-24,05%)
2,16M
AILEiLearningEngines Inc
US$ 0,5932
(267,31%)
563,26M
GTIGraphjet Technology
US$ 0,967551
(185,83%)
398,95M
RGTIRigetti Computing Inc
US$ 17,08
(10,62%)
305,79M
XTIAXTI Aerospace Inc
US$ 0,03935
(-1,63%)
268M
QSIQuantum Si Inc
US$ 3,585
(66,74%)
256,01M

ADAG Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock